Asia’s largest pharmaceutical company Takeda and Kazakhstan-British Technical University (KBTU) signed a Memorandum of Understanding (MoU) on Tuesday 25 June at KBTU on developing cooperation in the field of education, research, internships and joint project development.

Takeda was represented by the Director of Takeda Asia-Caucasus, Arminas Matsevichus, who signed the MoU on the behalf of Takeda Kazakhstan and KBTU Rector Kenzhebek Ibrashev signed the document from the University side.

The memorandum provides for the training of highly qualified scientific and pedagogical personnel, possibility of joint masters degree programs, organization of guest lectures, seminars and master classes. Also various advanced training programs and exchange of experience.

Takeda is a global pharmaceutical company, founded in 1781 in Japan. Today Takeda ranks among the fifteen largest in the world in terms of revenue. Takeda's work is based on the latest research and development and age-old corporate values. The main therapeutic areas of the company are : oncology, gastroenterology, neurology, rare diseases, plasma derivative therapy, vaccines.